Corix Bioscience, Inc.

Equities

CXBS

US21887N1037

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 03:43:00 2024-01-08 pm EST			5-day change	1st Jan Change
0.000001 ^USD	-99.00%		-.--%	-99.00%

2018	Corix Bioscience, Inc. Terminates Employment of Michael Ogburn, Chief Executive Officer	CI
2018	CanAfrica Holdings acquired Pharmaceutical Development Company Ltd from Corix Bioscience, Inc. for CAD 7 million.	CI

Corix Bioscience, Inc. Announces Resignation of Joaquin Flores as Director

August 04, 2017 at 12:09 pm EDT

On July 31, 2017, Corix Bioscience, Inc. received a notice of resignation from Joaquin Flores as a director on the Board of Directors. Pursuant to the Bylaws of the company, the Board may nominate and appoint a successor director.

Latest news about Corix Bioscience, Inc.

Corix Bioscience, Inc. Terminates Employment of Michael Ogburn, Chief Executive Officer	18-06-18	CI
CanAfrica Holdings acquired Pharmaceutical Development Company Ltd from Corix Bioscience, Inc. for CAD 7 million.	18-06-17	CI
Corix Bioscience, Inc. announced that it expects to receive $0.1 million in funding	18-04-19	CI
Corix Bioscience, Inc. Announces Management Resignations	18-04-19	CI
Corix Bioscience Inc Announces Joint Venture with ChampRX	18-01-18	CI
Corix Bioscience, Inc. acquired 25% stake in Champ Rx.	18-01-17	CI
Corix Bioscience, Inc. acquired Pharmaceutical Development Company Ltd from Sentinelle Global Investments (Proprietary) Limited, David Lamont Manaway, Clifford Elphick and Maria Elisabeth Findt for $2.2 million.	17-11-06	CI
Corix Bioscience, Inc. Signs Sales Agreement for Up to 22,000 Pounds of Hemp Per Month with Positively Green Organics LLC	17-08-16	CI
Corix Bioscience Announces New Tissue Culture and Research Lab	17-08-11	CI
Corix Bioscience, Inc. Announces Resignation of Joaquin Flores as Director	17-08-04	CI
American Housing Income Trust, Inc. has Changed its Name to Corix Bioscience, Inc	17-08-02	CI
Corix Bioscience, Inc. has Changed its Ticker to CXBS from AHIT	17-08-02	CI
Northern New Mexico Properties, LLC acquired remaining stake in AHIT Northern NM Properties, LLP from Corix Bioscience, Inc. for $0.04 million.	17-07-24	CI
Corix Bioscience, Inc. announced that it has received $0.2 million in funding from FirstFire Capital Management LLC	17-04-03	CI
IX Biotechnology, Inc acquired American Housing Income Trust, Inc. in a reverse merger transaction.	17-03-13	CI

Chart Corix Bioscience, Inc.

Duration

Period

More charts

Company Profile

Corix Bioscience, Inc., formerly American Housing Income Trust, Inc., is an organic biotechnology company. The Company is engaged in providing cannabidiol (CBD) oil, which is used for a wide variety of medicinal purposes. It is also engaged in cultivating and extracting tetrahydrocannabivarin (THCV) oil. It clones all of its plants based off of three original types: Otto, Cherry Wine and Georges Pet. It operates in Oregon, California and Nevada, United States.

Sector

Biotechnology & Medical Research

More about the company

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
CORIX BIOSCIENCE, INC.	-99.00%	20
VERTEX PHARMACEUTICALS INCORPORATED	-2.31%	103B
REGENERON PHARMACEUTICALS, INC.	+0.56%	95.28B
ARGENX SE	+1.69%	22.15B
BIONTECH SE	-17.37%	21.02B
GENMAB A/S	-9.30%	18.15B
WUXI APPTEC CO., LTD.	-41.01%	16.73B
BEIGENE, LTD.	-14.85%	16.05B
NEUROCRINE BIOSCIENCES, INC.	+3.21%	13.68B
SAREPTA THERAPEUTICS, INC.	+33.54%	12.17B

Bio Therapeutic Drugs